MedPath

General drug-use survey for Corectim

Not Applicable
Conditions
Dermatitis atopic
Registration Number
JPRN-jRCT2031210295
Lead Sponsor
Dept. and Pharmacovigilance Patient Safety
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Recruiting
Sex
All
Target Recruitment
3000
Inclusion Criteria

(1) Patients using Corectim for the first time for dermatitis atopic
(2) Patients or their surrogates must provide informed consent before the start

Exclusion Criteria

None

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath